3 results
Approved WMORecruiting
Assessment of safety and clinical performance of the DREAMS 3G in de novo coronary artery lesion in order to achieve and to obtain CE-approval
Approved WMORecruiting
To investigate the mechanism of fatigue and inflammation in IBD using clinical biomarkers, transcriptomic and epigenetic sequencing, and an innovative health patch.
Approved WMORecruiting
Primary Objective- To evaluate immunogenicity of N9-GP (nonacog beta pegol)Secondary Objectives- To evaluate safety of N9-GP (nonacog beta pegol)- To evaluate efficacy of N9-GP (nonacog beta pegol) * in long-term prophylaxis treatment * in theā¦